REIT - Residential
Compare Stocks
5 / 10Stock Comparison
NXRT vs IRT vs NVCR vs ELME vs BRT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
Medical - Instruments & Supplies
REIT - Office
REIT - Residential
NXRT vs IRT vs NVCR vs ELME vs BRT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Residential | REIT - Residential | Medical - Instruments & Supplies | REIT - Office | REIT - Residential |
| Market Cap | $748M | $3.89B | $1.81B | $192M | $272M |
| Revenue (TTM) | $252M | $662M | $674M | $0.00 | $97M |
| Net Income (TTM) | $-32M | $48M | $-173M | $-154M | $-12M |
| Gross Margin | 91.1% | 20.2% | 75.2% | — | 26.2% |
| Operating Margin | 11.5% | 17.5% | -27.2% | — | 11.4% |
| Forward P/E | — | 100.7x | — | — | — |
| Total Debt | $1.56B | $2.28B | $290M | $520M | $508M |
| Cash & Equiv. | $14M | $48M | $103M | $1.33B | $25M |
NXRT vs IRT vs NVCR vs ELME vs BRT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NexPoint Residentia… (NXRT) | 100 | 92.2 | -7.8% |
| Independence Realty… (IRT) | 100 | 166.8 | +66.8% |
| NovoCure Limited (NVCR) | 100 | 23.6 | -76.4% |
| Elme Communities (ELME) | 100 | 9.8 | -90.2% |
| BRT Apartments Corp. (BRT) | 100 | 128.1 | +28.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NXRT vs IRT vs NVCR vs ELME vs BRT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NXRT ranks third and is worth considering specifically for dividends.
- 7.2% yield, 12-year raise streak, vs ELME's 33.5%, (1 stock pays no dividend)
IRT is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 7.3% margin vs NVCR's -25.7%
- 0.8% ROA vs NVCR's -16.5%, ROIC 1.6% vs -16.4%
NVCR is the clearest fit if your priority is growth exposure.
- Rev growth 8.3%, EPS growth 21.8%, 3Y rev CAGR 6.8%
- 8.3% revenue growth vs ELME's -100.0%
ELME carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.47, yield 33.5%
- Lower volatility, beta 0.47, current ratio 1.02x
- Beta 0.47, yield 33.5%, current ratio 1.02x
- Better valuation composite
BRT is the clearest fit if your priority is long-term compounding.
- 214.2% 10Y total return vs NXRT's 216.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.3% revenue growth vs ELME's -100.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 7.3% margin vs NVCR's -25.7% | |
| Stability / Safety | Beta 0.47 vs NVCR's 2.20 | |
| Dividends | 7.2% yield, 12-year raise streak, vs ELME's 33.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +8.2% vs NXRT's -17.3% | |
| Efficiency (ROA) | 0.8% ROA vs NVCR's -16.5%, ROIC 1.6% vs -16.4% |
NXRT vs IRT vs NVCR vs ELME vs BRT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
NXRT vs IRT vs NVCR vs ELME vs BRT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ELME leads in 2 of 6 categories
NXRT leads 1 • IRT leads 1 • NVCR leads 0 • BRT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NXRT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVCR and ELME operate at a comparable scale, with $674M and $0 in trailing revenue. IRT is the more profitable business, keeping 7.3% of every revenue dollar as net income compared to NVCR's -25.7%. On growth, NVCR holds the edge at +12.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $252M | $662M | $674M | $0 | $97M |
| EBITDAEarnings before interest/tax | $125M | $365M | -$165M | -$44M | $37M |
| Net IncomeAfter-tax profit | -$32M | $48M | -$173M | -$154M | -$12M |
| Free Cash FlowCash after capex | $79M | $139M | -$48M | $62M | $14M |
| Gross MarginGross profit ÷ Revenue | +91.1% | +20.2% | +75.2% | — | +26.2% |
| Operating MarginEBIT ÷ Revenue | +11.5% | +17.5% | -27.2% | — | +11.4% |
| Net MarginNet income ÷ Revenue | -12.7% | +7.3% | -25.7% | — | -12.3% |
| FCF MarginFCF ÷ Revenue | +31.2% | +21.1% | -7.1% | — | +14.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.5% | +2.5% | +12.3% | -4.0% | +3.6% |
| EPS Growth (YoY)Latest quarter vs prior year | 0.0% | -101.4% | -100.0% | -6.6% | -109.1% |
Valuation Metrics
ELME leads this category, winning 2 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, IRT's 16.8x EV/EBITDA is more attractive than BRT's 20.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $748M | $3.9B | $1.8B | $192M | $272M |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $6.1B | $2.0B | -$620M | $755M |
| Trailing P/EPrice ÷ TTM EPS | -23.40x | 68.75x | -13.02x | -1.23x | -21.90x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 100.67x | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 18.53x | 16.80x | — | — | 20.19x |
| Price / SalesMarket cap ÷ Revenue | 2.98x | 5.91x | 2.76x | — | 2.80x |
| Price / BookPrice ÷ Book value/share | 2.49x | 1.08x | 5.20x | 0.80x | 1.47x |
| Price / FCFMarket cap ÷ FCF | 8.95x | 26.54x | — | 3.08x | 25.13x |
Profitability & Efficiency
IRT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
IRT delivers a 1.3% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-51 for NVCR. IRT carries lower financial leverage with a 0.64x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), IRT scores 6/9 vs BRT's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | +1.3% | -50.8% | -18.9% | -6.3% |
| ROA (TTM)Return on assets | -1.7% | +0.8% | -16.5% | -8.3% | -1.7% |
| ROICReturn on invested capital | +1.1% | +1.6% | -16.4% | -15.3% | +1.3% |
| ROCEReturn on capital employed | +1.5% | +2.4% | -28.9% | -10.1% | +1.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 4 | 3 |
| Debt / EquityFinancial leverage | 5.18x | 0.64x | 0.85x | 2.18x | 2.87x |
| Net DebtTotal debt minus cash | $1.5B | $2.2B | $187M | -$812M | $483M |
| Cash & Equiv.Liquid assets | $14M | $48M | $103M | $1.3B | $25M |
| Total DebtShort + long-term debt | $1.6B | $2.3B | $290M | $520M | $508M |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 1.73x | -96.80x | -3.82x | 0.51x |
Total Returns (Dividends Reinvested)
ELME leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IRT five years ago would be worth $12,187 today (with dividends reinvested), compared to $787 for NVCR. Over the past 12 months, ELME leads with a +8.2% total return vs NXRT's -17.3%. The 3-year compound annual growth rate (CAGR) favors ELME at 4.0% vs NVCR's -38.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.5% | -5.3% | +21.0% | -3.9% | +1.7% |
| 1-Year ReturnPast 12 months | -17.3% | -11.9% | -10.6% | +8.2% | +0.2% |
| 3-Year ReturnCumulative with dividends | -17.1% | +9.0% | -76.7% | +12.4% | +0.2% |
| 5-Year ReturnCumulative with dividends | -20.9% | +21.9% | -92.1% | -12.5% | +7.6% |
| 10-Year ReturnCumulative with dividends | +216.0% | +202.0% | +40.0% | -10.0% | +214.2% |
| CAGR (3Y)Annualised 3-year return | -6.1% | +2.9% | -38.5% | +4.0% | +0.1% |
Risk & Volatility
Evenly matched — ELME and BRT each lead in 1 of 2 comparable metrics.
Risk & Volatility
ELME is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than NVCR's 2.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BRT currently trades 86.6% from its 52-week high vs ELME's 12.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.62x | 0.48x | 2.20x | 0.47x | 0.65x |
| 52-Week HighHighest price in past year | $38.64 | $19.71 | $20.06 | $17.68 | $16.69 |
| 52-Week LowLowest price in past year | $23.79 | $14.60 | $9.82 | $1.98 | $13.18 |
| % of 52W HighCurrent price vs 52-week peak | +76.3% | +83.7% | +79.2% | +12.2% | +86.6% |
| RSI (14)Momentum oscillator 0–100 | 67.6 | 64.3 | 76.7 | 52.2 | 50.0 |
| Avg Volume (50D)Average daily shares traded | 222K | 2.3M | 1.6M | 1.2M | 54K |
Analyst Outlook
Evenly matched — NXRT and ELME each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NXRT as "Hold", IRT as "Buy", NVCR as "Buy", ELME as "Hold", BRT as "Buy". Consensus price targets imply 779.6% upside for ELME (target: $19) vs -8.4% for NXRT (target: $27). For income investors, ELME offers the higher dividend yield at 33.48% vs IRT's 3.99%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $27.00 | $20.08 | $33.50 | $19.00 | $21.00 |
| # AnalystsCovering analysts | 10 | 27 | 15 | 8 | 5 |
| Dividend YieldAnnual dividend ÷ price | +7.2% | +4.0% | — | +33.5% | +7.3% |
| Dividend StreakConsecutive years of raises | 12 | 4 | — | 0 | 0 |
| Dividend / ShareAnnual DPS | $2.11 | $0.66 | — | $0.72 | $1.05 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | +0.8% | 0.0% | 0.0% | +1.8% |
ELME leads in 2 of 6 categories (Valuation Metrics, Total Returns). NXRT leads in 1 (Income & Cash Flow). 2 tied.
NXRT vs IRT vs NVCR vs ELME vs BRT: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is NXRT or IRT or NVCR or ELME or BRT a better buy right now?
For growth investors, NovoCure Limited (NVCR) is the stronger pick with 8.
3% revenue growth year-over-year, versus -100. 0% for Elme Communities (ELME). Independence Realty Trust, Inc. (IRT) offers the better valuation at 68. 8x trailing P/E (100. 7x forward), making it the more compelling value choice. Analysts rate Independence Realty Trust, Inc. (IRT) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NXRT or IRT or NVCR or ELME or BRT?
Over the past 5 years, Independence Realty Trust, Inc.
(IRT) delivered a total return of +21. 9%, compared to -92. 1% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: NXRT returned +216. 0% versus ELME's -10. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NXRT or IRT or NVCR or ELME or BRT?
By beta (market sensitivity over 5 years), Elme Communities (ELME) is the lower-risk stock at 0.
47β versus NovoCure Limited's 2. 20β — meaning NVCR is approximately 371% more volatile than ELME relative to the S&P 500. On balance sheet safety, Independence Realty Trust, Inc. (IRT) carries a lower debt/equity ratio of 64% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — NXRT or IRT or NVCR or ELME or BRT?
By revenue growth (latest reported year), NovoCure Limited (NVCR) is pulling ahead at 8.
3% versus -100. 0% for Elme Communities (ELME). On earnings-per-share growth, the picture is similar: Independence Realty Trust, Inc. grew EPS 41. 2% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, BRT leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NXRT or IRT or NVCR or ELME or BRT?
Independence Realty Trust, Inc.
(IRT) is the more profitable company, earning 8. 6% net margin versus -20. 8% for NovoCure Limited — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRT leads at 18. 4% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is NXRT or IRT or NVCR or ELME or BRT more undervalued right now?
Analyst consensus price targets imply the most upside for ELME: 779.
6% to $19. 00.
07Which pays a better dividend — NXRT or IRT or NVCR or ELME or BRT?
In this comparison, ELME (33.
5% yield), BRT (7. 3% yield), NXRT (7. 2% yield), IRT (4. 0% yield) pay a dividend. NVCR does not pay a meaningful dividend and should not be held primarily for income.
08Is NXRT or IRT or NVCR or ELME or BRT better for a retirement portfolio?
For long-horizon retirement investors, Independence Realty Trust, Inc.
(IRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 4. 0% yield, +202. 0% 10Y return). NovoCure Limited (NVCR) carries a higher beta of 2. 20 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IRT: +202. 0%, NVCR: +40. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between NXRT and IRT and NVCR and ELME and BRT?
These companies operate in different sectors (NXRT (Real Estate) and IRT (Real Estate) and NVCR (Healthcare) and ELME (Real Estate) and BRT (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NXRT is a small-cap income-oriented stock; IRT is a small-cap income-oriented stock; NVCR is a small-cap quality compounder stock; ELME is a small-cap income-oriented stock; BRT is a small-cap income-oriented stock. NXRT, IRT, ELME, BRT pay a dividend while NVCR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.